Compare PCVX & OR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCVX | OR |
|---|---|---|
| Founded | 2013 | 2014 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 7.4B |
| IPO Year | 2020 | 2014 |
| Metric | PCVX | OR |
|---|---|---|
| Price | $49.89 | $36.81 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | ★ $88.25 | $47.00 |
| AVG Volume (30 Days) | ★ 1.6M | 678.0K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.60% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $105.04 |
| Revenue Next Year | N/A | $20.68 |
| P/E Ratio | ★ N/A | $55.77 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.10 | $24.77 |
| 52 Week High | $65.00 | $48.06 |
| Indicator | PCVX | OR |
|---|---|---|
| Relative Strength Index (RSI) | 39.93 | 46.17 |
| Support Level | $42.30 | $35.09 |
| Resistance Level | $56.04 | $38.07 |
| Average True Range (ATR) | 2.47 | 1.37 |
| MACD | -0.51 | -0.14 |
| Stochastic Oscillator | 34.37 | 35.29 |
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
OR Royalties Inc is engaged in the business of acquiring and managing precious metal and other high-quality royalties, streams and similar interests. The Company owns a portfolio of royalties, streams, offtakes, options on royalty/stream financings and exclusive rights to participate in future royalty/stream financings on various projects. Geographically, it generates majority of its income from North America and also generates some portions of income from South America, Australia, Africa and Europe.